CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade GoodRx Holdings, Inc. - GDRX CFD

    6.78
    1.96%
    0.07
    Low: 6.55
    High: 6.77
    Market Trading Hours* (UTC) Open now
    Closes on Tuesday at 20:00

    Mon - Fri: 13:30 - 20:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    Trading сonditions
    Spread 0.07
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026179 %
    Charges from full value of position ($-4.97)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026179%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003957 %
    Charges from full value of position ($0.75)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003957%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 6.64
    Open* 6.57
    1-Year Change* 14.46%
    Day's Range* 6.55 - 6.77
    52 wk Range 4.14-9.37
    Average Volume (10 days) 2.52M
    Average Volume (3 months) 37.53M
    Market Cap 2.64B
    P/E Ratio 180.56
    Shares Outstanding 406.13M
    Revenue 737.73M
    EPS 0.04
    Dividend (Yield %) N/A
    Beta 1.34
    Next Earnings Date Feb 26, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Apr 22, 2024 6.64 -0.04 -0.60% 6.68 6.68 6.53
    Apr 19, 2024 6.66 0.06 0.91% 6.60 6.70 6.56
    Apr 18, 2024 6.71 0.25 3.87% 6.46 6.73 6.46
    Apr 17, 2024 6.48 0.02 0.31% 6.46 6.72 6.43
    Apr 16, 2024 6.51 0.08 1.24% 6.43 6.73 6.41
    Apr 15, 2024 6.52 -0.18 -2.69% 6.70 6.76 6.43
    Apr 12, 2024 6.79 -0.01 -0.15% 6.80 6.89 6.77
    Apr 11, 2024 6.90 -0.03 -0.43% 6.93 6.93 6.67
    Apr 10, 2024 6.97 0.12 1.75% 6.85 6.99 6.68
    Apr 9, 2024 6.70 -0.05 -0.74% 6.75 7.08 6.66
    Apr 8, 2024 6.82 -0.02 -0.29% 6.84 6.98 6.76
    Apr 5, 2024 6.85 0.31 4.74% 6.54 6.86 6.54
    Apr 4, 2024 6.67 -0.08 -1.19% 6.75 6.82 6.61
    Apr 3, 2024 6.68 0.08 1.21% 6.60 6.80 6.60
    Apr 2, 2024 6.76 -0.10 -1.46% 6.86 6.93 6.66
    Apr 1, 2024 7.08 0.06 0.85% 7.02 7.11 6.92
    Mar 28, 2024 7.07 0.15 2.17% 6.92 7.24 6.92
    Mar 27, 2024 6.99 -0.05 -0.71% 7.04 7.16 6.88
    Mar 26, 2024 7.04 -0.05 -0.71% 7.09 7.45 6.93
    Mar 25, 2024 7.03 -0.47 -6.27% 7.50 7.84 7.03

    GoodRx Holdings, Inc. Events

    Time (UTC) Country Event
    Wednesday, May 8, 2024

    Time (UTC)

    12:30

    Country

    US

    Event

    Q1 2024 GoodRx Holdings Inc Earnings Release
    Q1 2024 GoodRx Holdings Inc Earnings Release

    Forecast

    -

    Previous

    -
    Thursday, May 9, 2024

    Time (UTC)

    12:00

    Country

    US

    Event

    Q1 2024 GoodRx Holdings Inc Earnings Call
    Q1 2024 GoodRx Holdings Inc Earnings Call

    Forecast

    -

    Previous

    -
    Thursday, June 13, 2024

    Time (UTC)

    18:00

    Country

    US

    Event

    Goodrx Holdings Inc Annual Shareholders Meeting
    Goodrx Holdings Inc Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    Wednesday, August 7, 2024

    Time (UTC)

    12:30

    Country

    US

    Event

    Q2 2024 GoodRx Holdings Inc Earnings Release
    Q2 2024 GoodRx Holdings Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 766.554 745.424 550.7 388.224 249.522
    Revenue 766.554 745.424 550.7 388.224 249.522
    Cost of Revenue, Total 65.079 46.716 29.587 14.016 6.035
    Gross Profit 701.475 698.708 521.113 374.208 243.487
    Total Operating Expense 764.816 732.018 826.419 253.425 175.128
    Selling/General/Admin. Expenses, Total 487.341 524.903 715.586 191.659 112.536
    Research & Development 143.137 125.86 61.816 29.3 43.894
    Depreciation / Amortization 54.177 34.539 18.43 13.573 9.806
    Operating Income 1.738 13.406 -275.719 134.799 74.394
    Interest Income (Expense), Net Non-Operating -24.969 -23.583 -27.753 -48.854 -22.039
    Other, Net 0 0 0.022 -2.967 -0.007
    Net Income Before Taxes -23.231 -10.177 -303.45 82.978 52.348
    Net Income After Taxes -32.828 -25.254 -293.623 66.048 43.793
    Net Income Before Extra. Items -32.828 -25.254 -293.623 66.048 43.793
    Net Income -32.828 -25.254 -293.623 66.048 43.793
    Income Available to Common Excl. Extra. Items -32.828 -25.254 -293.623 66.048 43.793
    Income Available to Common Incl. Extra. Items -32.828 -25.254 -293.623 66.048 43.793
    Diluted Net Income -32.828 -25.254 -293.623 66.048 43.793
    Diluted Weighted Average Shares 412.858 409.981 274.696 383.223 383.223
    Diluted EPS Excluding Extraordinary Items -0.07951 -0.0616 -1.0689 0.17235 0.11428
    Dividends per Share - Common Stock Primary Issue 0 0 0
    Diluted Normalized EPS -0.04353 -0.03893 -1.06654 0.18248 0.12051
    Unusual Expense (Income) 15.082 0 1 4.877 2.857
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 189.677 183.986 184.109 187.318 191.798
    Revenue 189.677 183.986 184.109 187.318 191.798
    Cost of Revenue, Total 16.339 16.695 17.36 17.395 18.044
    Gross Profit 173.338 167.291 166.749 169.923 173.754
    Total Operating Expense 171.369 174.491 182.372 203.031 195.845
    Selling/General/Admin. Expenses, Total 107.648 108.141 121.257 117.107 126.077
    Research & Development 31.285 32.908 36.77 35.921 35.404
    Depreciation / Amortization 16.097 14.939 15.533 13.952 13.319
    Operating Income 18.308 9.495 1.737 -15.713 -4.047
    Interest Income (Expense), Net Non-Operating -6.24 -5.899 -6.482 -6.558 -6.112
    Net Income Before Taxes 12.068 3.596 -4.745 -22.271 -10.159
    Net Income After Taxes 58.786 -3.29 -1.972 -41.734 -1.415
    Net Income Before Extra. Items 58.786 -3.29 -1.972 -41.734 -1.415
    Net Income 58.786 -3.29 -1.972 -41.734 -1.415
    Income Available to Common Excl. Extra. Items 58.786 -3.29 -1.972 -41.734 -1.415
    Income Available to Common Incl. Extra. Items 58.786 -3.29 -1.972 -41.734 -1.415
    Diluted Net Income 58.786 -3.29 -1.972 -41.734 -1.415
    Diluted Weighted Average Shares 414.335 412.429 411.67 412.956 412.135
    Diluted EPS Excluding Extraordinary Items 0.14188 -0.00798 -0.00479 -0.10106 -0.00343
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS 0.14248 -0.00346 -0.02028 -0.06244 0.00579
    Other, Net
    Unusual Expense (Income) 0 1.808 -8.548 18.656 3.001
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 919.686 1088.83 1086.37 86.582 73.071
    Cash and Short Term Investments 757.165 941.109 968.691 26.05 34.6
    Cash 757.165 941.109 968.691 26.05 34.6
    Total Receivables, Net 121.665 126.411 97.293 48.129 35.023
    Accounts Receivable - Trade, Net 117.141 118.08 68.729 48.129 33.359
    Prepaid Expenses 40.856 21.307 17.484 12.403 3.448
    Total Assets 1604.63 1607.62 1470.11 386.796 314.791
    Property/Plant/Equipment, Total - Net 55.726 49.317 50.769 34.175 0.988
    Property/Plant/Equipment, Total - Gross 65.495 55.146 52.899 35.442 1.542
    Accumulated Depreciation, Total -9.769 -5.829 -2.13 -1.267 -0.554
    Goodwill, Net 412.117 329.696 261.116 236.225 220.42
    Intangibles, Net 189.937 133.778 56.719 26.445 18.27
    Other Long Term Assets, Total 27.165 6.007 15.142 3.369 2.042
    Total Current Liabilities 76.32 81.113 59.551 33.373 16.62
    Accounts Payable 17.7 17.501 10.291 7.851 7.2
    Accrued Expenses 43.712 49.714 35.379 13.691 3.732
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 7.029 7.029 7.029 7.029 5.43
    Other Current Liabilities, Total 7.879 6.869 6.852 4.802 0.258
    Total Liabilities 789.804 775.945 758.755 737.369 740.209
    Total Long Term Debt 651.796 655.858 659.888 663.893 716.806
    Long Term Debt 651.796 655.858 659.888 663.893 716.806
    Deferred Income Tax 0.244 3.456
    Other Liabilities, Total 61.688 38.73 39.316 40.103 3.327
    Total Equity 814.827 831.68 711.359 -350.573 -425.418
    Redeemable Preferred Stock 0 0 737.009 737.009
    Common Stock 0.04 0.04 0.039 0.46 0.451
    Retained Earnings (Accumulated Deficit) -1448.54 -1415.71 -1390.45 -1096.83 -1162.88
    Total Liabilities & Shareholders’ Equity 1604.63 1607.62 1470.11 386.796 314.791
    Total Common Shares Outstanding 397.025 398.681 391.66 383.223 383.223
    Additional Paid-In Capital 2263.32 2247.35 2101.77 8.788
    Other Current Assets, Total 0 2.9
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 969.098 919.252 907.016 919.686 878.388
    Cash and Short Term Investments 794.905 761.988 761.075 757.165 728.786
    Cash 794.905 761.988 761.075 757.165 728.786
    Total Receivables, Net 124.608 123.378 116.442 121.665 124.25
    Accounts Receivable - Trade, Net 121.146 123.378 116.442 117.141 120.886
    Prepaid Expenses 46.485 33.886 29.499 40.856 25.352
    Other Current Assets, Total 3.1
    Total Assets 1707.97 1692.1 1611.5 1604.63 1567.06
    Property/Plant/Equipment, Total - Net 48.38 51.461 53.683 55.726 50.258
    Goodwill, Net 412.117 412.117 412.117 412.117 415.256
    Intangibles, Net 181.41 202.135 197.303 189.937 197.199
    Other Long Term Assets, Total 96.967 107.137 41.381 27.165 25.958
    Total Current Liabilities 117.822 82.553 68.981 76.32 84.966
    Accounts Payable 32.905 6.795 12.389 17.7 10.855
    Accrued Expenses 62.814 42.452 35.062 43.712 56.084
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 7.029 7.029 7.029 7.029 7.029
    Other Current Liabilities, Total 15.074 26.277 14.501 7.879 10.998
    Total Liabilities 826.699 796.731 784.032 789.804 778.656
    Total Long Term Debt 648.729 649.753 650.776 651.796 652.814
    Long Term Debt 648.729 649.753 650.776 651.796 652.814
    Other Liabilities, Total 60.148 64.425 64.275 61.688 40.226
    Total Equity 881.273 895.371 827.468 814.827 788.403
    Common Stock 0.04 0.04 0.04 0.04 0.04
    Additional Paid-In Capital 2312.77 2288.37 2279.25 2263.32 2234.93
    Retained Earnings (Accumulated Deficit) -1431.53 -1393.04 -1451.82 -1448.54 -1446.56
    Total Liabilities & Shareholders’ Equity 1707.97 1692.1 1611.5 1604.63 1567.06
    Total Common Shares Outstanding 398.362 396.672 396.649 397.025 396.065
    Redeemable Preferred Stock 0 0 0 0
    Deferred Income Tax 0.65
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -32.828 -25.254 -293.623 66.048 43.793
    Cash From Operating Activities 146.78 178.779 131.341 83.286 45.253
    Cash From Operating Activities 54.177 34.539 18.43 13.573 9.806
    Deferred Taxes -0.497 12.851 -10.91 -5.674 -2.433
    Non-Cash Items 146.218 168.439 449.903 14.155 5.858
    Cash Taxes Paid -4.356 18.105 29.228 19.4 11.7
    Cash Interest Paid 30.702 20.198 24.517 48.443 18.658
    Changes in Working Capital -20.29 -11.796 -32.459 -4.816 -11.771
    Cash From Investing Activities -210.498 -178.733 -91.617 -37.055 -3.458
    Capital Expenditures -55.214 -34.457 -35.824 -5.749 -3.458
    Other Investing Cash Flow Items, Total -155.284 -144.276 -55.793 -31.306 0
    Cash From Financing Activities -120.226 -30.528 905.817 -54.781 -24.734
    Financing Cash Flow Items -20.635 -58.52 15.043 -2.214 -1371.97
    Issuance (Retirement) of Stock, Net -92.562 35.021 897.803 4.665 740.358
    Issuance (Retirement) of Debt, Net -7.029 -7.029 -7.029 -57.232 606.876
    Net Change in Cash -183.944 -30.482 945.541 -8.55 17.061
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -3.29 -32.828 -30.856 10.878 12.293
    Cash From Operating Activities 32.288 146.78 114.901 81.169 30.12
    Cash From Operating Activities 14.939 54.177 38.644 24.692 11.373
    Deferred Taxes 0.035 -0.497 -0.141 -0.336 -0.394
    Non-Cash Items 29.198 146.218 112.553 65.241 31.732
    Changes in Working Capital -8.594 -20.29 -5.299 -19.306 -24.884
    Cash From Investing Activities -14.288 -210.498 -211.784 -198.009 -34.401
    Capital Expenditures -14.288 -55.214 -39.924 -26.149 -12.418
    Cash From Financing Activities -14.09 -120.226 -115.44 -93.729 -91.401
    Financing Cash Flow Items -3.523 -20.635 -17.557 -14.288 -9.561
    Issuance (Retirement) of Stock, Net -8.809 -92.562 -92.611 -75.926 -80.082
    Issuance (Retirement) of Debt, Net -1.758 -7.029 -5.272 -3.515 -1.758
    Net Change in Cash 3.91 -183.944 -212.323 -210.569 -95.682
    Other Investing Cash Flow Items, Total 0 -155.284 -171.86 -171.86 -21.983

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    GoodRx Holdings, Inc. Company profile

    GoodRx is a startup company that operates a telemedicine platform and a free-to-use website and mobile app that track prescription drug prices in the United States and provide free drug coupons for discounts on medications. GoodRx checks more than 75,000 pharmacies in the United States. The website gets about fourteen million visitors a month. As of February 25, 2020, "millions of people" had downloaded the GoodRx app.
    Industry: Online Services (NEC)

    2701 Olympic Boulevard
    Suite 990
    SANTA MONICA
    CALIFORNIA 90404
    US

    Income Statement

    • Annual
    • Quarterly

    News

    We’re partnering with Newsquawk

    Filter out the noise and focus on the news that matters.

    08:32, 23 April 2024

    US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft

    The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.

    15:56, 22 April 2024

    Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

    Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

    07:56, 17 April 2024

    US Earnings Season : JP Morgan, Citigroup, Wells Fargo

    The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

    16:03, 11 April 2024

    Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

    The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

    09:22, 11 April 2024

    US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

    US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

    15:11, 9 April 2024

    How escalating geopolitical tensions are impacting oil markets

    The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

    13:34, 4 April 2024

    People also watch

    BTC/USD

    67,014.50 Price
    +0.310% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 106.00

    XRP/USD

    0.55 Price
    -2.860% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 21:00 (UTC)
    Spread 0.01168

    US100

    17,458.40 Price
    +1.310% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 21:00 (UTC)
    Spread 1.8

    ETH/USD

    3,252.78 Price
    +1.600% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 6.00

    Still looking for a broker you can trust?

    Join the 610,000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading